Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Signaling Pathways

Items 2661-2670 of 9364

Page
per page
  1. MY-5445
    B6301 MY-5445
    Summary: PDE5 inhibitor
      Soluble in DMSO
  2. SC-9
    B6302 SC-9
    Summary: protein kinase C activator
      <10.05 mg/mL
  3. Cimaterol
    B6303 Cimaterol
    Summary: β-Adrenergic agonist
      Soluble in DMSO
  4. Etazolate hydrochloride
    B6304 Etazolate hydrochloride
     2 Citation
    Target: Phosphodiesterases (PDEs)
    Summary: PDE-4 inhibitor and selective GABA-A receptor modulator
      ≥7.75 mg/mL
  5. 6-Chloromelatonin
    B6307 6-Chloromelatonin
    Summary: melatonin agonist
      Soluble to 100 mM in DMSO
  6. Cinanserin hydrochloride
    B6309 Cinanserin hydrochloride
    Summary: 5-HT2 antagonist
      Soluble to 50 mM in H2O
  7. Nitrocaramiphen hydrochloride
    B6311 Nitrocaramiphen hydrochloride
    Summary: M1 muscarinic antagonist
      ≥4.69 mg/mL
  8. (+)-U-50488 hydrochloride
    B6312 (+)-U-50488 hydrochloride
    Summary: Selective κ-opioid agonist
      <40.58 mg/mL
  9. Alrestatin
    B6319 Alrestatin
    Summary: aldose reductase inhibitor
  10. 1,3-Dipropyl-8-phenylxanthine
    B6320 1,3-Dipropyl-8-phenylxanthine
    Summary: A1 adenosine antagonist
      insoluble in ethanol;insoluble in DMSO

Items 2661-2670 of 9364

Page
per page